| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.4780258252806924 2.2006060058015637 0.0277639280599009 0.9999999484829214 1.0 56 P14406,P03886,O43676,P00846,Q9Y6N1,Q99643,O14949,Q7KZN9,Q9UDW1,P12235,O75306,Q9Y6M9,O75964 13 |
| Vitamin a and carotenoid metabolism 0.9074619712356772 2.1529336190609234 0.0313238958663186 0.9999999942132128 1.0 4 Q8WTV0,P09455 2 |
| Kennedy pathway from sphingolipids 0.8005339796396516 2.1124393676463766 0.0346487813613785 0.9999999992544648 1.0 6 Q9HBU6,O95470,Q9BVG9,P35790 4 |
| Cholesterol biosynthesis with skeletal dysplasias 0.784633961509599 2.0518413897063708 0.0401850793965472 0.9999999999758038 1.0 7 Q15392,Q15125,Q16850 3 |
| Vitamin dsensitive calcium signaling in depression 0.7799919830655015 2.0213148038976927 0.0432471876559739 0.9999999999963972 1.0 6 Q8NB78,P00390 2 |
| Oxidation by cytochrome p450 0.7664242911109842 1.969680904271131 0.048874952845356 0.999999999999893 1.0 7 Q6UW02,Q16850,O43169 3 |
| Sphingolipid metabolism integrated pathway 0.7496700031078436 1.915375469743676 0.0554446371757648 0.9999999999999984 1.0 9 Q96G23,O15270,O95470,P27544,O15269 5 |
| Sphingolipid metabolism overview 0.7496700031078436 1.915375469743676 0.0554446371757648 0.9999999999999984 1.0 9 Q96G23,O15270,O95470,P27544,O15269 5 |
| Metabolism of spingolipids in er and golgi apparatus 0.7246425010082926 1.7713630128578035 0.0765003551027514 1.0 1.0 6 O95470 1 |
| Nanomaterial induced apoptosis 0.7617425730091595 1.7660721267346096 0.0773837490336193 1.0 1.0 5 O95831 1 |
| Eicosanoid metabolism via lipooxygenases lox 0.7167208256993433 1.7350845513040294 0.0827258302229729 1.0 1.0 6 Q14914,Q15067 2 |
| Eicosanoid metabolism via cyclooxygenases cox 0.7145536320762363 1.725138628736411 0.0845024925040835 1.0 1.0 6 Q14914,Q15067 2 |
| Glycerolipids and glycerophospholipids 0.7088862749442763 1.705495827858461 0.0881019897402879 1.0 1.0 7 Q9HBU6,Q9BVG9,Q9UG56,O96017 4 |
| Sulfation biotransformation reaction 0.8738638221298075 1.6375039802464295 0.1015252079644608 1.0 1.0 3 P00390 1 |
| Omega3 omega6 fatty acid synthesis 0.6835007418314264 1.5816852536181951 0.1137214407645743 1.0 1.0 6 O15254,Q15067 2 |
| Mitochondrial complex iv assembly 0.6522931965956147 1.5528347393962916 0.1204626210022716 1.0 1.0 16 P14406,Q9Y241,Q7KZN9,P13073,Q9P0S2,Q9Y6N1 6 |
| Sphingolipid pathway 0.6701225809961875 1.5476803031121884 0.1216992866548993 1.0 1.0 10 Q96G23,O15270,O95470,P04062,O15269 5 |
| Proteoglycan biosynthesis 0.6742195779551406 1.5384883523352233 0.1239292542941674 1.0 1.0 6 Q8WVQ1,Q8NCH0,Q8TB61,O43909 4 |
| Sphingolipid metabolism in senescence 0.6613484321724252 1.5158527430793094 0.1295565919458461 1.0 1.0 11 Q96G23,O15269,P04062 3 |
| Heme biosynthesis 0.74866703273531 1.51205789651612 0.1305191345460845 1.0 1.0 4 P22830,P36551 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7030293662329805 1.509683839187555 0.1311241168950359 1.0 1.0 5 O60725 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5948958733442128 1.507479647045224 0.1316877569307464 1.0 1.0 25 P48449,Q14739,Q15392,Q16850,Q9BWD1,Q15800,Q15125 7 |
| Nad biosynthetic pathways 0.8373172263271855 1.4986355938139435 0.1339681935579633 1.0 1.0 3 P43490 1 |
| Nad metabolism 0.8373172263271855 1.4986355938139435 0.1339681935579633 1.0 1.0 3 P43490 1 |
| Apoptosis modulation by hsp70 0.8350220570631187 1.4898911286134064 0.1362528645558827 1.0 1.0 3 O95831 1 |
| Vitamin d metabolism 0.8332495422209334 1.4831364853110296 0.1380381520492761 1.0 1.0 3 P38435 1 |
| Allograft rejection 0.6557600724833528 1.4615063464333256 0.143876535168121 1.0 1.0 8 P42224,P08670,P08183,P10321 4 |
| Mitochondrial complex ii assembly 0.8157406631075329 1.4163577927830306 0.1566707749116513 1.0 1.0 3 Q99643 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.6381456042779127 1.4122420543542775 0.157878701688537 1.0 1.0 12 P13674,O15460,Q96AY3,O75718,Q32P28 5 |
| Triacylglyceride synthesis 0.6413762097567979 1.3846091526368864 0.1661720112931477 1.0 1.0 6 Q9NUQ2,O00116 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6326988628704632 1.3437280497279145 0.1790363434243003 1.0 1.0 6 Q9BXK5,Q07820,P49841,Q9HB09 4 |
| Familial partial lipodystrophy fpld 0.6227279143240491 1.308017520508381 0.1908673667419329 1.0 1.0 9 O75844,O60725,P49354 3 |
| Influence of laminopathies on wnt signaling 0.6187639698663744 1.2954828107900085 0.1951537273125101 1.0 1.0 10 O75844,O60725 2 |
| Congenital generalized lipodystrophy cgl 0.7786757848927588 1.2748683623201342 0.2023558388608104 1.0 1.0 3 P31751,P62993 2 |
| Circadian rhythm genes 0.4303603481904783 1.2723906800140286 0.2032343438405748 1.0 1.0 40 P54802,P43490,Q03164,P04818,P54646,P00813,Q14103,Q9NRV9,Q15233,Q9BWF3,P23246 11 |
| Nonalcoholic fatty liver disease 0.3819378746211779 1.256883116657887 0.2087959629546429 1.0 1.0 53 Q86Y39,P14406,P31930,Q99643,O43676,O14949,Q9UDW1,P54646,P31751,O75306,Q9Y6M9 11 |
| Serine metabolism 0.6039650296613062 1.2078896036023687 0.2270897290719515 1.0 1.0 6 P00374,P04818,O43175,P34897 4 |
| Mecp2 and associated rett syndrome 0.5743673777857273 1.1955697424762968 0.2318645049603791 1.0 1.0 19 P31943,O75475,P35637,Q03518,Q14353 5 |
| Mthfr deficiency 0.6298270777767311 1.1850759295305204 0.2359874271172923 1.0 1.0 5 P49419 1 |
| Adipogenesis 0.5807426359636897 1.1716971974785126 0.2413186486080514 1.0 1.0 16 P43490,Q9NZ45 2 |
| Fatty acid betaoxidation 0.5611822916268535 1.1698172077994768 0.2420745372407713 1.0 1.0 21 O43772,P43304,Q9UKU0 3 |
| Ketogenesis and ketolysis 0.5931993959189689 1.157594660855091 0.2470294891271982 1.0 1.0 7 O43772,P53985 2 |
| Endothelin pathways 0.5848817971094844 1.1195119032545209 0.2629218156543778 1.0 1.0 8 P42892 1 |
| Glycerophospholipid biosynthetic pathway 0.5846632803191834 1.1167013315201588 0.2641220483519109 1.0 1.0 7 O95674,O00116,Q8WUK0 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.575256608539144 1.1140452834950882 0.265259760348064 1.0 1.0 14 O75844,O60725,P49354 3 |
| Nitric oxide metabolism in cystic fibrosis 0.6517412935323332 1.109922864011981 0.2670322670648559 1.0 1.0 4 Q86X55,Q99873,O60678 3 |
| Ethanol effects on histone modifications 0.5804720849459704 1.1058104728245917 0.2688085610922344 1.0 1.0 10 P00374,P04818,P41440,P05091 4 |
| Statin inhibition of cholesterol production 0.6503016450315899 1.103961460863052 0.2696098558603368 1.0 1.0 4 Q8WTV0 1 |
| Progeriaassociated lipodystrophy 0.5761426397702449 1.0843449793395707 0.2782118691637767 1.0 1.0 10 O75844,O60725 2 |
| Vitamin d receptor pathway 0.5676940753751062 1.0550554368182452 0.2913999713956516 1.0 1.0 12 Q5VV42,P11413,P08183 3 |
| Vitamin b12 disorders 0.6347143696631692 1.0395470806257652 0.2985503738491659 1.0 1.0 4 Q9H3L0,Q96EY8 2 |
| Mevalonate pathway 0.5957727092480251 1.033808478012519 0.3012257074263149 1.0 1.0 5 Q9BWD1 1 |
| Alzheimers disease and mirna effects 0.393801531596692 1.029867434031167 0.303072239940259 1.0 1.0 80 P60900,P16615,P21796,Q13885,P45880,P49721,P28070,P28074,Q99436,P25788,P31751,Q02750,Q13509,O95197,P49720,P12236,P49841,P20618,Q96IX5,Q9NQC3,Q9BVA1,P67870,Q13564,P04350,P07437,P12235,O14654,P68371 28 |
| Mitochondrial immune response to sarscov2 0.5649421290085607 1.025143344655466 0.3052955561162835 1.0 1.0 9 Q9Y6M9,Q7Z434 2 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.5544497723727092 0.9738501988916844 0.3301309240572583 1.0 1.0 9 Q02750 1 |
| Alzheimers disease 0.3864076305216909 0.9650430639943378 0.3345232426637317 1.0 1.0 79 P60900,P16615,P21796,Q13885,P45880,P49721,P28070,P28074,Q99436,P25788,P31751,Q02750,Q13509,O95197,P49720,P12236,P49841,P20618,Q9NQC3,Q9BVA1,P67870,Q13564,P04350,P07437,P12235,O14654,P68371 27 |
| Relationship between inflammation cox2 and egfr 0.6148390056453611 0.9578826393478542 0.3381219415716914 1.0 1.0 4 P31751 1 |
| Histone modifications 0.540041032486568 0.905551302308634 0.3651733941548944 1.0 1.0 6 Q03164,Q9H7B4 2 |
| Urea cycle and related diseases 0.8642013673088731 0.905114016759579 0.3654049871375311 1.0 1.0 2 Q9Y619 1 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.6804054339013224 0.9042158934531356 0.3658809342176963 1.0 1.0 3 P31751 1 |
| Il9 signaling pathway 0.5353483128295189 0.8812595040069278 0.3781773792013219 1.0 1.0 7 P42224,Q02750,P62993 3 |
| Il7 signaling pathway 0.5353483128295187 0.8812595040069253 0.3781773792013232 1.0 1.0 7 P42224,Q02750,P49841 3 |
| Disorders of folate metabolism and transport 0.5350740653266115 0.8790323382774219 0.37938374212324 1.0 1.0 8 P00374,P04818,P34897 3 |
| Pdgfrbeta pathway 0.5341062702746324 0.8776930752161671 0.380110303451397 1.0 1.0 6 P42224,Q02750,P62993 3 |
| Kisspeptinkisspeptin receptor system in the ovary 0.531598890026447 0.8659446569800331 0.3865205120505188 1.0 1.0 6 Q02750 1 |
| Cerebral organic acidurias including diseases 0.5553281109380097 0.8559152727616841 0.3920446464567333 1.0 1.0 5 P49419,P48735 2 |
| Cholesterol biosynthesis pathway 0.5253823138618214 0.8469328194537168 0.3970325680634539 1.0 1.0 13 P48449,Q16850,Q15800 3 |
| Nocgmppkg mediated neuroprotection 0.5245679934359762 0.8330776833064896 0.4048009188379189 1.0 1.0 6 P30536,P07196 2 |
| Onecarbon metabolism and related pathways 0.5179083101617029 0.8247267770084652 0.4095267259142547 1.0 1.0 15 P00390,P32929,P04818,Q9HBU6,P34897,P35790,Q99707,O15382,P48507 9 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5159106218415758 0.7875725847381007 0.43094675592799 1.0 1.0 8 P31943 1 |
| Metapathway biotransformation phase i and ii 0.465956691372727 0.7677970850401976 0.4426077465799132 1.0 1.0 27 Q8NCH0,P00390,Q7LGA3,Q16850,P78417,P07099,Q9NRB3,Q86UY6 8 |
| Oxidative phosphorylation 0.4204828836957671 0.7507512011978927 0.4528024026224293 1.0 1.0 34 P03886,P00846,O75306,Q9Y6M9,O75964 5 |
| Ferroptosis 0.4678874073456699 0.7484641676539343 0.4541802305501554 1.0 1.0 26 Q9NZ45,P45880,Q9UKU0 3 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.5044881024608036 0.733579373816404 0.4632051357197073 1.0 1.0 8 Q02750,Q15418 2 |
| Cancer immunotherapy by pd1 blockade 0.6322660864159213 0.7299734646057235 0.465406404646544 1.0 1.0 3 P04439,P40763 2 |
| Il5 signaling pathway 0.5022214322423662 0.7297551986363431 0.4655398339849408 1.0 1.0 13 P62993,Q15418,P49841,Q02750,P42224 5 |
| Mitochondrial complex i assembly model oxphos system 0.4357354332426135 0.7169751385364281 0.4733894370923435 1.0 1.0 31 P03886,O43676,Q96CU9,O75306,Q9Y6M9 5 |
| Vitamin b12 metabolism 0.4953656789675272 0.6938777729454704 0.4877588638162837 1.0 1.0 7 Q8WTV0,P34897,Q96EY8,P32929 4 |
| Cellular proteostasis 0.5485074626865605 0.692589026994865 0.4885674984849446 1.0 1.0 4 Q9UHV9,O60925,P61758 3 |
| Mitochondrial complex iii assembly 0.4949400836641492 0.686486931075331 0.4924061027458699 1.0 1.0 10 O14949,Q6DKK2,Q9UDW1 3 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.4923629343948406 0.6748503372064172 0.4997708556628519 1.0 1.0 9 P56545,P67870,Q86UE4 3 |
| Angiotensin ii receptor type 1 pathway 0.616412806963015 0.6745245218373014 0.4999779010332035 1.0 1.0 3 Q06124,P63244 2 |
| Bdnftrkb signaling 0.4794876131926933 0.6173180113455164 0.5370249889900176 1.0 1.0 8 Q02750 1 |
| Sars coronavirus and innate immunity 0.7734617775015484 0.604066781940048 0.5457992433395091 1.0 1.0 2 Q7Z434 1 |
| Ccl18 signaling pathway 0.4762772485495119 0.599752169871253 0.5486714139714852 1.0 1.0 9 P11166,Q86UE4,P07196,P08670 4 |
| Mirna biogenesis 0.5943425551756363 0.5994232546336331 0.548890673483202 1.0 1.0 3 Q9HAV4,Q8WYQ5 2 |
| Disruption of postsynaptic signaling by cnv 0.4686790824339493 0.5680980916981746 0.5699683634788675 1.0 1.0 8 Q06787,Q14168,Q13555 3 |
| Biomarkers for pyrimidine metabolism disorders 0.4661686685594074 0.5567741420984281 0.577681753005105 1.0 1.0 8 Q7LG56,P04818,Q9Y606,Q9H0P0 4 |
| Interleukin11 signaling pathway 0.4635298006366035 0.537785086033578 0.5907254294367361 1.0 1.0 11 P42224,Q02750,P62993,Q15418 4 |
| Tlr4 signaling and tolerance 0.5008624703360546 0.5145756148294758 0.606849608862033 1.0 1.0 4 Q15629 1 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.4730929774015113 0.511906987237967 0.6087161077840622 1.0 1.0 5 P32929 1 |
| Tryptophan metabolism 0.4561205530391922 0.5099803450761021 0.6100652317844846 1.0 1.0 15 Q15392 1 |
| Head and neck squamous cell carcinoma 0.4538335345258306 0.4931671990357891 0.6218944523616752 1.0 1.0 13 P62942,P54646 2 |
| Leptininsulin signaling overlap 0.7355500310752076 0.4907898442661074 0.6235750936910474 1.0 1.0 2 O14654 1 |
| Copper homeostasis 0.4483667552840309 0.489750100957601 0.6243107444052891 1.0 1.0 6 P05067,P49841,Q9Y6N1 3 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.4513957535321837 0.481680298242956 0.6300330739283344 1.0 1.0 13 P43490,Q8IXJ6 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.4491310065032824 0.4710558117983719 0.6376008794081856 1.0 1.0 13 O43772 1 |
| 1q211 copy number variation syndrome 0.4477256179943872 0.4706046386523174 0.6379230944878875 1.0 1.0 9 Q9NPH0 1 |
| 16p112 distal deletion syndrome 0.4455662026135389 0.4656285859853454 0.641481377754022 1.0 1.0 8 Q9H2V7,P20339,P62993 3 |
| Iron metabolism in placenta 0.7224984462398996 0.4540771755435146 0.6497732805591516 1.0 1.0 2 P02786 1 |
| Folate metabolism 0.4439543393975816 0.4509798958751634 0.6520040386786119 1.0 1.0 15 P00374,P32929,P41440,P34897,Q99707,Q8WTV0 6 |
| Glutathione metabolism 0.4368018008623804 0.4339500733538861 0.6643246967425274 1.0 1.0 7 P00390 1 |
| Epo receptor signaling 0.4366707719108571 0.4273995922746685 0.6690883043382918 1.0 1.0 8 P42224,Q02750,P62993 3 |
| Fluoropyrimidine activity 0.4317433899718028 0.3939986236415007 0.6935820553963163 1.0 1.0 11 P00374,Q06203 2 |
| Embryonic stem cell pluripotency pathways 0.4308738303300586 0.3902041161540357 0.6963856181506856 1.0 1.0 11 P31751,Q02750,P62993,P49841 4 |
| Target of rapamycin tor signaling 0.4242876671621797 0.3617422002927696 0.7175446883750618 1.0 1.0 11 P62942 1 |
| Apoptosis 0.4116584695456169 0.3243698984686842 0.7456580063254228 1.0 1.0 8 Q9NR28,Q13546 2 |
| Il10 antiinflammatory signaling pathway 0.4196731588883371 0.3152511141370765 0.7525709991244329 1.0 1.0 5 P09601,P42224,P53004 3 |
| Egfr tyrosine kinase inhibitor resistance 0.4133725119425894 0.3094274606597884 0.7569963840650127 1.0 1.0 14 P31751,Q02750,P62993,P49841 4 |
| Rala downstream regulated genes 0.4378109452736232 0.3078108360649665 0.7582262756848952 1.0 1.0 4 P63000,Q96KP1,P11233 3 |
| Type i interferon induction and signaling during sarscov2 infection 0.4956188399204491 0.306691057952582 0.7590785367194941 1.0 1.0 3 Q7Z434 1 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.4125992736151876 0.291646462084002 0.7705569473600207 1.0 1.0 5 Q9Y3Z3 1 |
| Pi3kaktmtor vitd3 signaling 0.3925736529902569 0.26739753690576 0.7891630956841733 1.0 1.0 6 P54646,P49841 2 |
| Selenium micronutrient network 0.4012216712098798 0.2624571954146139 0.7929689820189338 1.0 1.0 12 P00390,P32929,P30048,Q9C0D9,Q8WTV0 5 |
| Nrf2are regulation 0.3929012038988309 0.2600356911185234 0.7948362427825391 1.0 1.0 7 P09601,P49841,P48507 3 |
| Amyotrophic lateral sclerosis als 0.4001994444254556 0.2583418072771955 0.7961431234857708 1.0 1.0 12 Q9BUN8,P07196,P07197 3 |
| Inclusion body myositis 0.6354878806712339 0.2466095765544398 0.8052103924042289 1.0 1.0 2 P05067 1 |
| Pilocytic astrocytoma 0.6320696084524464 0.2399493816700593 0.81036949785418 1.0 1.0 2 P62993 1 |
| Apoptosis modulation and signaling 0.3959091210999436 0.2344886670480519 0.8146056303525886 1.0 1.0 15 O95831,Q9NR28 2 |
| Wnt signaling 0.3936843685890714 0.2266482275314941 0.820697287847258 1.0 1.0 14 Q13555,P67870,Q8TAA9,Q9ULK5,P56545 5 |
| Omega9 fatty acid synthesis 0.3770215119729226 0.2125735886172244 0.831659573835094 1.0 1.0 6 O95864 1 |
| Pyrimidine metabolism and related diseases 0.3787341190932777 0.2012571459446863 0.8404975094985223 1.0 1.0 8 Q7LG56,P04818,Q9H0P0 3 |
| S1p receptor signal transduction 0.3781448205910609 0.1992059808316624 0.8421016211563128 1.0 1.0 8 P31751,Q13510 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.346031261780945 0.1870162009062216 0.851647930559742 1.0 1.0 33 P11166,P46108,Q15418,P13807,O00767,P51812,P54646,P31751,O14654,P41440,Q02750 11 |
| Proteasome degradation 0.3128977330983415 0.1865787107912553 0.8519909599420088 1.0 1.0 39 P60900,P28074,Q99436,P28070,P25788,P49720,P20618,P49721 8 |
| Exrna mechanism of action and biogenesis 0.6009944064636531 0.1850186213698273 0.8532144299842832 1.0 1.0 2 Q8WYQ5 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.4395399440472595 0.1845983890426886 0.8535440495857198 1.0 1.0 3 P28482,P40763 2 |
| Ppar signaling pathway 0.3815918461422466 0.17612100521022 0.860198879088198 1.0 1.0 18 P23786,Q9UKU0,Q15067 3 |
| Erk pathway in huntingtons disease 0.5950901180857788 0.1757355755610072 0.8605016849692821 1.0 1.0 2 P28482 1 |
| Notch signaling 0.3738724727838139 0.175152101942052 0.8609601195508625 1.0 1.0 5 P56545,Q92769,Q92542,Q13363 4 |
| Fluoroacetic acid toxicity 0.3718536685026422 0.1697231061708995 0.8652279016096833 1.0 1.0 5 P51648 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.373269489034961 0.1677980810587334 0.8667421321886823 1.0 1.0 10 Q13546,Q7Z434 2 |
| Purine metabolism and related disorders 0.3762211971467328 0.1559013608825933 0.8761107725974544 1.0 1.0 15 O15067,P00813,Q06203 3 |
| Spinal cord injury 0.3763719765514826 0.1545601150089028 0.8771681156652691 1.0 1.0 18 P62942,Q9NQC3,P14174,P08670 4 |
| Transsulfuration pathway 0.3647428911825704 0.154174062226438 0.8774724929939555 1.0 1.0 8 Q99707,P25325,P32929 3 |
| Transcription cofactors ski and skil protein partners 0.3737562189054677 0.1477980250015868 0.8825021680413743 1.0 1.0 4 O14744,Q96ST3,P51608 3 |
| 15q112 copy number variation syndrome 0.361660824804202 0.124427957241752 0.9009764386713666 1.0 1.0 4 Q9BSJ2,Q06787 2 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3616011374328263 0.121917308489862 0.9029645076926592 1.0 1.0 11 Q9BWD1 1 |
| Praderwilli and angelman syndrome 0.3514774494556759 0.1188130405075298 0.9054234770387376 1.0 1.0 5 Q7L576,P11802,Q00534,Q15154 4 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.3846792772582958 0.1030152598580213 0.91795085977332 1.0 1.0 3 P48507 1 |
| Mirna regulation of prostate cancer signaling pathways 0.3497167198250124 0.0992312244548368 0.9209546836691256 1.0 1.0 9 Q02750,P62993 2 |
| Steroid biosynthesis 0.5307644499689388 0.0978697073057826 0.922035754545923 1.0 1.0 2 Q99829 1 |
| Kit receptor signaling pathway 0.3599023112705892 0.093443977330756 0.9255508544740592 1.0 1.0 16 P46108,P62993,Q15418,P51812,Q02750,P42224 6 |
| Genes related to primary cilium development based on crispr 0.3533399961503971 0.0833588033501327 0.933566244623681 1.0 1.0 13 O95684,Q10713 2 |
| Familial hyperlipidemia type 4 0.504661280298337 0.0774600162971932 0.9382575980405063 1.0 1.0 2 Q9UBV2 1 |
| Mammary gland development pathway involution stage 4 of 4 0.3512589368977357 0.07105632624214 0.9433529268762152 1.0 1.0 3 P40763,Q07812 2 |
| Robo4 and vegf signaling pathways crosstalk 0.4928527035425885 0.0700525909881632 0.9441518008584656 1.0 1.0 2 O94813 1 |
| Nonsmall cell lung cancer 0.3494862384440683 0.0659319218032614 0.9474320259429398 1.0 1.0 14 P31751,Q02750,P62993 3 |
| Methylation pathways 0.3416226297793039 0.064052054666233 0.9489287782377464 1.0 1.0 3 P21964,P31153 2 |
| Endometrial cancer 0.3447944446780694 0.0628391916347348 0.9498945571108516 1.0 1.0 12 P31751,Q02750,P62993 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3403906123059066 0.0499386820116855 0.9601712519566667 1.0 1.0 12 Q9UI14,P07196,Q9NR77 3 |
| Neovascularisation processes 0.4394033561218325 0.0480262334879159 0.9616953354256268 1.0 1.0 2 P28482 1 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.4394033561218325 0.0480262334879159 0.9616953354256268 1.0 1.0 2 P28482 1 |
| G1 to s cell cycle control 0.3442123787259226 0.0418505353500243 0.9666178488916026 1.0 1.0 24 Q14566,P25205,Q9Y619,Q07864 4 |
| 7oxoc and 7betahc pathways 0.3350076282740721 0.0418449990907556 0.9666222623212276 1.0 1.0 11 Q15125,O15118 2 |
| Nucleotide metabolism 0.3432844400583212 0.0417698867991622 0.9666821409063692 1.0 1.0 15 P00374,Q7LG56,P19623 3 |
| Nephrotic syndrome 0.3412435060291351 0.0404821293146794 0.9677087541028536 1.0 1.0 14 O75844 1 |
| Microrna network associated with chronic lymphocytic leukemia 0.3511497824735972 0.0366630507595173 0.970753670045627 1.0 1.0 2 Q07820 1 |
| Purinergic signaling 0.3225605966438895 0.0358590792518812 0.9713947248928356 1.0 1.0 2 P63096 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.342612763085622 0.029442275526921 0.9765118564112848 1.0 1.0 18 Q14739,Q02750,P42166,P50402 4 |
| Il6 signaling pathway 0.3325782060188945 0.0281141797676485 0.977571084725 1.0 1.0 12 P42224,Q02750,P62993,P49841 4 |
| Il2 signaling pathway 0.3282076034304867 0.023816716535296 0.9809988059646232 1.0 1.0 11 P42224,Q02750,P62993 3 |
| Kallmann syndrome 0.2739427860696428 0.0200771503855676 0.983981827822424 1.0 1.0 4 Q06124,P62993,P28482 3 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.273320895522381 0.0196968431049067 0.9842852091297272 1.0 1.0 4 Q13155,P09601,P48507 3 |
| Riboflavin and coq disorders 0.306727933246483 0.0184909396437605 0.9852472054482162 1.0 1.0 6 O75208,Q8NI60 2 |
| Retinoblastoma gene in cancer 0.2553346458786922 0.0155318322835433 0.9876078890629434 1.0 1.0 49 P00374,Q14566,P25205,Q9Y619,P04818,Q16204,P09455 7 |
| Cytosine methylation 0.2360074626865604 0.0034882768900075 0.9972167633700976 1.0 1.0 4 P48735,O75874,P51608 3 |
| Nuclear receptors metapathway 0.250337546734152 0.0034107211185773 0.9972786435545488 1.0 1.0 46 P00390,Q14914,Q15067,P08183,P23786 5 |
|
|
